New developments in the diagnosis of maternal and congenital CMV infection

References

• Britt WJ, Alford CA. Cytomegalovirus. In: Fields Virology Ord Edition). Fields BN, Knipe P, Howley M (Eds.), Lippincott-Raven Publishers, Philadelphia, USA, 2493–2523 (1996).
   Google Scholar
• Stagno S. Cytomegalovirus. In: Infectious Diseases of the Fetus and Newborn Infant (4th Edition). Remington JS, Klein JO (Eds.), W B. Saunders, Philadelphia, USA, 312–353 (1995).
   Google Scholar
• ••Excellent overview of CMV.
   Google Scholar
• Boppana SB, Pass RF, Britt WJ, Stagno S, Alford CA. Symptomatic congenital cytomegalovirus infection: Neonatal morbidity and mortality. Perliatc Infect. Dis.j 11, 93–99 (1992).
   Google Scholar
• Boppana SB, Fowler KB, Britt WJ, Stagno S, Pass RE Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus. Perliatc 104, 55–60 (1999).
   Google Scholar
• Nielsen SL, Sorensen I, Andersen HK. Kinetics of specific immunoglobulins M, E, A and G in congenital, primary and secondary cytomegalovirus infection studied by antibody-capture enzyme-linked immunosorbent assay. j Clin. Nlicrobiol 26, 654–661 (1988).
   Google Scholar
• Lipitz S, Yagel S, Shalev E, Achiron R, Mashiach S, Schiff E. Prenatal diagnosis of fetal primary cytomegalovirus infection. Obstet. Gynecol 89, 763–767 (1997).
   PubMed Web of Science ®Google Scholar
• Lazzarotto T, Guerra B, Spezzacatena P et al Prenatal diagnosis of congenital cytomegalovirus infection. j Gun. Nlicrobiol 36, 3540–3544 (1998).
   Web of Science ®Google Scholar
• Revello MG, Sarasini A, Zavattoni M, Baldanti F, Gerna G. Improved prenatal diagnosis of congenital human cytomegalovirus infection by a modified nested polymerase chain reaction. J. Merl Viral 56, 99–103 (1998). 91. a7zarotto T, Varani S, Guerra B, Nicolosi A, Lanari M, Landini MP. Prenatal indicators of congenital cytomegalovirus infection. j Perliatc 137, 90-95(2000). Describes recent advances in the prenatal diagnosis of CMV infection.
   Google Scholar
• Cope AV, Sabin C, Burroughs A, Rolles K, Griffiths PD, Emery VC. Interrelationships among quantity of human cytomegalovirus (HCMV) DNA in blood, donor-recipient serostatus and administration of methylprednisolone as risk factors for HCMV disease following liver transplantation. j Infect. Dis. 176, 1484–1490 (1997). itFox JC, Kidd IM, Griffiths PD, Sweny P, Emery VC. Longitudinal analysis of cytomegalovirus load in renal transplant recipients using a quantitative polymerase chain reaction: correlation with disease. Gen. Viral 76, 309–319 (1995).
   Google Scholar
• Guerra B, J .a7zarotto T, Quarta S eta]. Prenatal diagnosis of symptomatic congenital cytomegalovirus infection. Am. Obstet. Gynecol 183, 476–482 (2000). Describes recent advances in the prenatal diagnosis of CMV infection.
   Google Scholar
• Revello MG, Zavattoni M, Baldanti F, Sarasini A, Paolucci S, Gerna G. Diagnostic and prognostic value of human cytomegalovirus load and IgM antibody in blood of congenitally infected newborns. Clin. Viral 14, 57–66 (1999). Describes recent advances in the postnatal diagnosis of CMV infection.
   Google Scholar
• Kraat YJ, Stals FS, Christiaans MET, J.a7zarotto T, Landini MP, Bruggeman CA. IgM antibody detection of ppUL80a and ppUL32 by immunoblotting: an early parameter for recurrent cytomegalovirus infection in renal transplant recipients. Merl Viral 48, 289–294 (1996).
   Google Scholar
• Donner C, Liesnard C, Brancart F, Rodesch Accuracy of amniotic fluid testing before 21 weeks gestation in prenatal diagnosis of congenital cytomegalovirus infection. Prenat. Diagn.14, 1055–1059 (1994).
   Google Scholar
• Haukenes G, Viggen B, Boye B, Kalvenes MB, Flo R, Kalland IKH. Viral antibodies in infectious mononucleosis. HMS' Med. Mavbiol. 8, 219–224 (1994).
   Google Scholar
• Kamer W, Bauer G. Activation of varicella- zoster virus-specific IgA response during acute Epstein-Barr virus infection. I Merl Viral 44, 258–262 (1994).
   PubMed Web of Science ®Google Scholar
• Deyi YM, Goubau P, Bodéus M. False- positive IgM antibody tests for cytomegalovirus in patients with acute Epstein-Barr virus infection. Eur I Clin. Nlicrobiol. Infect. Dis. 19, 557–560 (2000).
   Google Scholar
• Aalto SM, Linnavuori K, Peltola H etal Immunoreactivation of Epstein-Barr virusdue to cytomegalovirus primary infection. Med. Vim]. 56, 186–191 (1998).
   Google Scholar
• Khameneh ZR, Soin J, Durlik M, Lao M, Paczsk L, Gaciong Z. Factors affecting reactivation of Epstein-Barr virus infection after kidney allograft transplantation. Ann. Transplant. 4, 18–22 (1999).
   PubMedGoogle Scholar
• Vaughan JH, Shaw PX, Nguyen MD etal Evidence of activation of 2 herpesviruses, Epstein-Barr virus and cytomegalovirus, in systemic sclerosis and normal skins. Rheumatol 27, 821–823 (2000).
   Web of Science ®Google Scholar
• Drouet E, Chapuis-Cellier C, Bosshard S et al Oligo-monoclonal immunoglobulins frequently develop during concurrent cytomegalovirus (CMV) and Epstein-Barr (EBV) infections in patients after renal transplantation. Clin. Exp. Immunol 118, 465–472 (1999).
   PubMed Web of Science ®Google Scholar
• Wakiguchi H, Hisakawa H, Kubota H, Kurashige T Strong response of T cells in infants with dual infection by Epstein-Barr virus and cytomegalovirus. Pediatr. int. 41, 484–489 (1999).
   PubMed Web of Science ®Google Scholar
• Lazzarotto T, Dalla Casa B, Campisi B, Landini MR Enzyme-linked immunoadsorbent assay for the detection of cytomegalovirus-IgM: Comparison between eight commercial kits, immunofluorescence and immunoblotting. Clin. Lab. Anal 6, 216–218 (1992).
   PubMed Web of Science ®Google Scholar
• ••
   Google Scholar
• Lazzarotto T, Brojanac S, Maine GT, Landini MP. Search for cytomegalovirus-specific immunoglobulin M: Comparison between a new Western blot, conventional Western blot and nine commercially available assays. Clin. Diagn. Lab. Imatunol. 4, 483–486 (1997).
   PubMedGoogle Scholar
• Chee MS, Bankier AT, Beck S etal Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Gun: Top. Microbial. Immunol 154, 125–169 (1990).
   Google Scholar
• •An analysis of the protein-coding content of human CMV strain AD169 DNA.
   Google Scholar
• Landini MP, Lazzarotto T, Maine GT, Ripalti A, Flanders R. Recombinant mono-and polyantigens to detect cytomegalovirus-specific immunoglobulin M in human sera by enzyme immunoassay. Clin. Mcrobiol 33, 2535–2542 (1995).
   Google Scholar
• Ripalti A, Dal Monte P, Boccuni MC etal. Prokaryotic expression of a large fragment of the most antigenic cytomegalovirus DNA-binding protein (ppUL44) and its reactivity with human antibodies. j Viral. Meth. 46, 39–50 (1994).
   Google Scholar
• Vornhagen R, Hinderer W, Sonneborg 1111 et al The DNA-binding protein pUL57 of human cytomegalovirus is a major target antigen for the immunoglobulin M antibody response during acute infection. Clin. Mcrobiol 33, 1927-1930 (1995).
   Google Scholar
• Bodéus M, Feyder S, Goubau P. Avidity of IgG antibodies distinguishes primary from non-primary cytomegalovirus infection in pregnant women. Clin. Diagn. Vim'. 9, 9–16(1998).
   Google Scholar
• •Covers the development and evaluation of avidity assays as serologic tests for CMV.
   Google Scholar
• Bodéus M, Goubau P. Predictive value of maternal-IgG avidity for congenital human cytomegalovirus infection. j Clin 12, 3–8 (1999).
   Google Scholar
• •Covers the development and evaluation of avidity assays as serologic tests for CMV.
   Google Scholar
• Grangeot-Keros L, Mayaux MJ, Lebon P et al Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary CMV infection in pregnant women. Infect. Dis. 175, 944–946 (1997).
   Web of Science ®Google Scholar
• •Covers the development and evaluation of avidity assays as serologic tests for CMV.
   Google Scholar
• Lazzarotto T, Spezzacatena P, Pradelli P, Abate DA, Varani S, Landini MR Avidity of immunoglobulin G directed against human cytomegalovirus during primary and secondary infections in immunocompetent and immunocompromised subjects. Clin. Diagn. Lab. Immunol 4, 469–473 (1997).
   PubMedGoogle Scholar
• •Covers the development and evaluation of avidity assays as serologic tests for CMV.
   Google Scholar
• Lazzarotto T, Spezzacatena P, Varani S etal Anticytomegalovirus (anti—CMV) immunoglobulin G avidity in identification of pregnant women at risk of transmitting congenital CMV infection. Clin. Diagn. Lab. Imatunol. 6,127–129 (1999).
   PubMedGoogle Scholar
• ••Covers the development and evaluation ofavidity assays as serologic tests for CMV.
   Google Scholar
• Lazzarotto T, Maine GT, Dal Monte P, Frush H, Shi K, Landini MR Detection of serum immunoglobulin M to human cytomegalovirus by western blotting correlates better with virological data than detection by conventional enzyme immunoassay. Clin. Diagn. Lab. Immunol 3, 597–600 (1996).
   PubMedGoogle Scholar
• Lazzarotto T, Maine GT, Dal Monte P, Ripalti A, Landini MP. A novel Western blot test containing both viral and recombinant proteins for anticytomegalovirus immunoglobulin M detection. j Clin. Mavbiol. 35, 393–397 (1997).
   Google Scholar
• •Covers the development and evaluation of CMV IgM imrnunoblot.
   Google Scholar
• Lazzarotto T, Ripalti A, Bergamini G eta]. Development of a new cytomegalovirus (CMV) immunoglobulin M (1gM) immunoblot for the detection of CMV-specific IgM. 1 Clin. Mavbiol. 36, 3337–3341 (1998).
   Google Scholar
• •Covers the development and evaluation of CMV IgM imrnunoblot.
   Google Scholar
• Maine GT, Stricker R, Schuler M eta]. Development and clinical evaluation of a recombinant-antigen-based cytomegalovirus immunoglobulin M automated immunoassay using the Abbott AxSYM analyzer. j Clin. Microbial. 38, 1476–1481 (2000).
   Google Scholar
• •Covers the development and evaluation of new CMV IgM assays.
   Google Scholar
• Greijer A, Van De Crommert JM, Stevens SJ, Middeldorp JM. Molecular fine-specificity analysis of antibody responses to human cytomegalovirus and design of novel synthetic-peptide-based serodiagnostic assays. j Clin Microbial. 37, 179–188 (1999).
   PubMed Web of Science ®Google Scholar
• •Covers the development and evaluation of new CMV IgM assays.
   Google Scholar
• Vornhagen R, Hinderer W Sonneborn 1111 etal IgM-specific serodiagnosis of acute human cytomegalovirus infection using recombinant autologous fusion proteins. Viral. Meth. 60, 73–80 (1996).
   Google Scholar
• •Covers the development and evaluation of new CMV IgM assays.
   Google Scholar
• Lazzarotto T, Galli C, Pulvirenti R eta]. Evaluation of the Abbott AxSYM cytomegalovirus (CMV) immunoglobulin M (IgM) assay in conjunction with other CMV IgM tests and a CMV IgG avidity assay. Clin Diagn. Lab. Immunol 8, 196–198 (2001).
   Google Scholar
• •Covers the development and evaluation of new CMV IgM assays.
   Google Scholar
• Lazzarotto T, Varani S, Gabrielli L, Spezzacatena P, Landini MR New advances in the diagnosis of congenital cytomegalovirus infection. Intervirol 42, 390–397 (1999).
   PubMed Web of Science ®Google Scholar
• •Describes the test methods used for CMV.
   Google Scholar
• Mathijs JM, Rawlinson WD, Jacobs S eta]. Cellular localization of human cytomegalovirus reactivation in the cervix. Infect. Dis. 163, 921–922 (1991).
   Google Scholar
• Shen CY, Chang SF, Yen MS, Ng HT, Huang ES, Wu CW. Cytomegalovirus excretion in pregnant and nonpregnant women. Clin. Microbial. 31, 1635–1636 (1993).
   PubMed Web of Science ®Google Scholar
• Revello MG, Zavattoni M, Sarasini A, Percivalle E, Simincini L, Gema G. Human cytomegalovirus in blood of immunocompetent persons during primary infection. Prognostic implications for pregnancy. Infect. Dis. 177, 1170–1175 (1998).
   Google Scholar
• Mulongo KN, Lamy ME, Van Lierde M. Requirements for diagnosis of prenatal cytomegalovirus infection by amniotic fluid culture. Clin. Diagn. Vim'. 4, 231–238 (1995).
   Google Scholar
• Ruellan-Eugene G, Barjot P, Campet M et al Evaluation of virological procedures to detect fetal human cytomegalovirus infection: Avidity of IgG antibodies, virus detection in amniotic fluid and maternal serum. j Med. Viral. 50, 9–15 (1996).
   PubMed Web of Science ®Google Scholar
• Fowler KB, Dahle AJ, Boppana SB, Pass RE Newborn hearing screening: will children with hearing loss caused by congenital cytomegalovirus be missed? Pedian 135, 60–64 (1999).
   Google Scholar
• Nelson CT, Demmler GJ. Cytomegalovirus infection in the pregnant mother, fetus and newborn infant. Infect. Perinat. 24, 151–160 (1997).
   Google Scholar
• Nigro G, La Torre R, Anceschi MM, Mazzocco M, Cosmi EV. Hyperimmunoglobulin therapy for a twin fetus with cytomegalovirus infection and growth restriction. Am. j Obstet. Gynecol 180, 1222–1226 (1999).
   PubMed Web of Science ®Google Scholar
• Negishi H, Yamada H, Hirayama etal Intraperitoneal administration of cytomegalovirus hyperimmunoglobulin to the cytomegalovirus-infected fetus. J. Perinat. 18, 466–469 (1998).
   PubMedGoogle Scholar
• Dal Monte P, Pignatelli S, Mach M, Landini MP. The product of human cytomegalovirus (HCMV) UL73 is a new polymorphic structural glycoprotein (gpUL73). j Human Viral. (2001) (In Press).
   Google Scholar
• Rawlinson WD. Broadsheet Number 50: Diagnosis of human cytomegalovirus infection and disease. Farhat 31, 109–115(1999).
   Google Scholar
• •Describes the test methods used for CMV.
   Google Scholar
• Boeckh M, Boivin G. Quantitation of cytomegalovirus: Methodologic aspects and clinical applications. Gun. Microbial. Rev 11, 533–554 (1998).
   PubMed Web of Science ®Google Scholar
• •Describes the test methods used for CMV.
   Google Scholar
• Fowler SL. A light in the darkness: Predicting outcomes for congenital cytomegalovirus infections. j Perliatr. 137, 4–6 (2000).
   Google Scholar
• •Reviews the recent advances in the prenatal diagnosis of CMV infection and their impact on clinical diagnosis.
   Google Scholar